Jain Global’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
+14,494
New +$931K ﹤0.01% 943
2026
Q1
Sell
-2,749
Closed -$220K 1388
2025
Q4
$220K Sell
2,749
-47,823
-95% -$3.21M ﹤0.01% 1035
2025
Q3
$2.46M Buy
50,572
+40,810
+418% +$2.53M 0.01% 495
2025
Q2
$728K Buy
9,762
+6,458
+195% +$428K 0.01% 703
2025
Q1
$210K Sell
3,304
-396
-11% -$26.9K ﹤0.01% 838
2024
Q4
$289K Buy
+3,700
New +$297K 0.01% 566

Other funds holding HAE

Jain Global's HAE Position: Q2 2026 in Review

Jain Global opened a new position in Haemonetics (HAE) in Q2 2026: 14,494 shares worth $1.09M. The stake represents ﹤0.01% of the portfolio and ranks #943 among its holdings. This is a return to the name: Jain Global previously reported a position in HAE as recently as Q4 2025.

Jain Global first reported a position in HAE in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.46M in Q3 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Jain Global held 14,494 shares of Haemonetics worth $1.09M as of Q2 2026.
  • Haemonetics was a new Jain Global position in Q2 2026.
  • Haemonetics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #943 holding.
  • Jain Global first reported a position in Haemonetics in Q4 2024 and has held it in 6 quarters since.
  • Jain Global's Haemonetics position peaked at $2.46M in Q3 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.